Covid-19 created many attractive opportunities for Novo Holdings in 2020
Even though Covid-19 caused a volatile market situation in 2020, the overall tailwind for the life science sector has also boosted Novo Holdings' life science investment portfolio, states CEO Kasim Kutay.
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN
The markets were in the middle of a heavy dive last year in March, when Novo Holdings presented its annual report. However, the holding and investment company saw major potential in this dive, and far along the way, the potential has been realized, Novo Holdings CEO tells Kasim Kutay.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Holdings beats records in 2020 and earns DKK 29bn
For subscribers
Novo Holdings appoints new head of responsible investments
For subscribers
.jpg&w=384&q=75)
